DRAGdb: Drug Resistance Associated Genes
Number of mutation entries related to Pyrazinamide resistance is 1187
PROVEAN score threshold is -2.5. Variants with score = or < -2.5 are considered deleterious.Variants with score > -2.5 are considered neutral.
| ORGANISM_NAME | GENE_NAME | ENSEMBL_ID | DRUG_NAME | NUCLEOTIDE_POSITION | NUCLEOTIDE_MUTATION | AMINOACID_POSITION | AMINOACID_MUTATION | PROVEAN_SCORE | SAMPLE_LOCATION |
|---|---|---|---|---|---|---|---|---|---|
| Mycobacterium tuberculosis | rpsA | Rv1630 | Pyrazinamide | 1420 | CGG - TGG | 474 | Arg - Trp | -1.598 | China |
| Mycobacterium tuberculosis | rpsA | Rv1630 | Pyrazinamide | 1421 | CGG - CTG | 474 | Arg - Leu | -1.125 | China |
| Mycobacterium tuberculosis | rpsA | Rv1630 | Pyrazinamide | 778 | GTC - ATC | 260 | Val - Ile | -0.933 | NA |
| Mycobacterium tuberculosis | rpsA | Rv1630 | Pyrazinamide | 1299 | GAG - GAC | 433 | Glu - Asp | -0.442 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 35 | GAC - GCC | 12 | Asp - Ala | -7.68 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 137 | GCA - GAA | 46 | Ala - Glu | -4.833 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GCG | 139 | Val - Ala | -3.712 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - His | -11.52 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GGG | 139 | Val - Gly | -6.511 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 460 | AGG - GGG | 154 | Arg - Gly | -5.57 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 305 | GCG - GTG | 102 | Ala - Val | -3.789 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 364 | CAA - TAA | 122 | Gln - Stop | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 216 | TGC - TGG | 72 | Cys - Trp | -10.817 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 153 | CAC - CAA | 51 | His - Gln | -7.728 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 153 | CAC - CAG | 51 | His - Gln | -7.728 | Poland |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 8 | GCG - GAG | 3 | Ala - Glu | -4.578 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 157 | GAC - AAC | 53 | Asp - Asn | -4.099 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 523 | ATG - GTG | 175 | Met - Val | -1.826 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 442 | CGC - AGC | 148 | Arg - Ser | -1.796 | Poland |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 218 | CGCATTGCCG - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 307 | TAC - GAC | 103 | Tyr - Asp | -9.72 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 248 | CCC - CGC | 83 | Pro - Arg | -8.75 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 151 | CAC - GAC | 51 | His - Asp | -8.696 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - GAC | 57 | His - Asp | -8.69 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CGG | 54 | Pro - Arg | -8.685 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 170 | CAC - CGC | 57 | His - Arg | -7.729 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CGC | 51 | His - Arg | -7.726 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 35 | GAC - GCC | 12 | Asp - Ala | -7.68 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 188 | GAC - GGC | 63 | Asp - Gly | -6.767 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 23 | GAC - GGC | 8 | Asp - Gly | -6.72 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 395 | GGT - GAT | 132 | Gly - Asp | -6.523 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 485 | GGT - GAT | 162 | Gly - Asp | -6.179 | Sierra Leone |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 211 | CAT - TAT | 71 | His - Tyr | -5.9 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 174 | TTC - TTG | 58 | Phe - Leu | -5.8 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | Sierra Leone |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 11 | TTG - TGG | 4 | Leu - Trp | -5.595 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 254 | CTG - CAG | 85 | Leu - Gln | -5.061 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 269 | ATC - AGC | 90 | Ile - Ser | -5.047 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 418 | CGC - AGC | 140 | Arg - Ser | -4.683 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 437 | GCG - GAG | 146 | Ala - Glu | -4.564 | Sierra Leone |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 199 | TCG - CCG | 67 | Ser - Pro | -4.512 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 538 | GTC - TTC | 180 | Val - Phe | -4.266 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 419 | CGC - CAC | 140 | Arg - His | -4.164 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 137 | GCA - GTA | 46 | Ala - Val | -3.856 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 512 | GCG - GTG | 171 | Ala - Val | -3.581 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 452 | TTG - TCG | 151 | Leu - Ser | -2.928 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 463 | GTG - ATG | 155 | Val - Met | -2.671 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 535 | AGC - CGC | 179 | Ser - Arg | -1.933 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 263 | TCG - TAG | 88 | Ser - Stop | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 15 | C - Insertion | NA | NA | NA | Sierra Leone |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 260 | C - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 282 | CT - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 339 | G - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 | G - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 392 | GG - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 408 | A - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 408 | G - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 446 | ATGGCTTG - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -13 | G - T | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | Sierra Leone |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 423 | ACGGCGCCAG - Insertion | NA | NA | NA | Sierra Leone |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 192 | T - Insertion | NA | NA | NA | Sierra Leone |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 214 | TGC - CGC | 72 | Cys - Arg | -11.8 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - Arg | -11.52 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 206 | CCA - CGA | 69 | Pro - Arg | -8.77 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 206 | CCA - CGA | 69 | Pro - Arg | -8.77 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 410 | CAT - CCT | 137 | His - Pro | -8.164 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 35 | GAC - GCC | 12 | Asp - Ala | -7.68 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 254 | CTG - CCG | 85 | Leu - Pro | -5.939 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 287 | AAG - ACG | 96 | Lys - Thr | -5.88 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - CCC | 47 | Thr - Pro | -5.625 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - AAG | 142 | Thr - Lys | -5.601 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - ATG | 142 | Thr - Met | -5.601 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 394 | GGT - AGT | 132 | Gly - Ser | -5.572 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 14 | ATC - AGC | 5 | Ile - Ser | -5.413 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 288 | AAG - AAT | 96 | Lys - Asn | -4.927 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 34 | GAC - AAC | 12 | Asp - Asn | -4.8 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 121 | TAC - CAC | 41 | Tyr - His | -4.23 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 24 | GAC - GAG | 8 | Asp - Glu | -3.84 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 77 | GCG - GGG | 26 | Ala - Gly | -2.085 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 353 | AAT - ACT | 118 | Asn - Thr | -1.901 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 1 | 8bp - Deletion | 1 | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 1 | 11bp - Deletion | 1 | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 28 | C - Deletion | 10 | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 71 | G - Deletion | 24 | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 100 | T - Insertion | 34 | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 162 | T - Insertion | 54 | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 263 | TCG - TAG | 88 | Ser - Stop | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 312 | C - Deletion | 104 | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 59 | C - Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 301 | A - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 368 | AG - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | CC - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 501 | CG - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 | G - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | TG - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 443 | G - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 446 | 8bp - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 475 | C - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 518 | 5bp - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 98 - 216 | 118bp - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - C | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 170 | CAC - CTC | 57 | His - Leu | -10.629 | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 186 | CCG - CTG | 62 | Pro - Leu | -9.657 | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 50 | GGC - GTC | 17 | Gly - Val | -8.64 | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 485 | GGT - GAT | 162 | "G ly - Asp" | -6.179 | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 62 | GTA - GGA | 21 | Val - Gly | -6.17 | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 56 | CTG - CGG | 19 | Leu - Arg | -5.654 | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 25 - 26 | GTG - TCG | 9 | Val - Ser | -5.476 | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 236 | GCG - GGG | 79 | Ala - Gly | -3.741 | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 554 | AGC - ATC | 185 | Ser - Ile | -2.41 | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 224 | ATG - ACG | 75 | Met - Thr | NA | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 47 | G - Deletion | 16 | NA | NA | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 64 | A - Deletion | NA | NA | NA | Hong Kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 68 | Trp - Arg | -13.64 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 203 | TGG - TTG | 68 | Trp - Leu | -12.633 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 203 | TGG - TTG | 68 | Trp - Leu | -12.633 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 170 | CAC - CTC | 57 | His - Leu | -10.629 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 413 | TGT - TAT | 138 | Cys - Tyr | -10.234 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 170 | CAC - CCC | 57 | His - Pro | -9.661 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CTG | 62 | Pro - Leu | -9.657 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CTG | 62 | Pro - Leu | -9.657 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 188 | GAC - GGC | 63 | Asp - Gly | -6.767 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 56 | CTG - CCG | 19 | Leu - Pro | -6.508 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 485 | GGT - GAT | 162 | Gly - Asp | -6.179 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 62 | GTA - GGA | 21 | Val - Gly | -6.17 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 287 | AAG - ACG | 96 | Lys - Thr | -5.88 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 347 | CTG - CGG | 116 | Leu - Arg | -5.828 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - TAC | 57 | His - Tyr | -5.798 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 56 | CTG - CGG | 19 | Leu - Arg | -5.654 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 394 | GGT - AGT | 132 | Gly - Ser | -5.572 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 25 - 26 | GTG - TCG | 9 | Val - Ser | -5.476 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 175 | TCC - CCC | 59 | Ser - Pro | -4.286 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 236 | GCG - GGG | 79 | Ala - Gly | -3.741 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 524 | ATG - ACG | 175 | Met - Thr | -3.596 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 554 | AGC - ATC | 185 | Ser - Ile | -2.41 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 196 | TCG - CCG | 66 | Ser - Pro | -2.208 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 197 | TCG - TTG | 66 | Ser - Pro | -2.208 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 78 | GCG - GCA | 26 | Ala - Ala | 0 | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 64 | A - Deletion | 22 | NA | NA | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 176 | TCC - TTC | 59 | Val - Phe | NA | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 203 | TGG - TAG | 68 | Trp - Stop | NA | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 47 | G - Deletion | NA | NA | NA | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 47 | G - Deletion | NA | NA | NA | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 473 | G - Insertion | NA | NA | NA | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 507 | C - Insertion | NA | NA | NA | Hong kong |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 68 | Trp - Arg | -13.64 | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 355 | TGG - CGG | 119 | Trp - Arg | -13.602 | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - GGG | 68 | Trp - Gly | -12.665 | Iran |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 214 | TGC - CGC | 72 | Cys - Arg | -11.8 | Iran |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 307 | TAC - GAC | 103 | Tyr - Asp | -9.72 | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | Iran |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 174 | TTC - TTG | 58 | Phe - Lys | -8.7 | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CGG | 54 | Pro - Arg | -8.685 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 212 | CAT - CGT | 71 | His - Arg | -7.867 | Iran |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 188 | GAC - GCC | 63 | Asp - Ala | -7.725 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 188 | GAC - GCC | 63 | Asp - Ala | -7.725 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 188 | GAC - GCC | 63 | Asp - Ala | -7.725 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 23 | GAC - GGC | 8 | Asp - Gly | -6.72 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 411 | CAT - CAG | 137 | His - Gln | -6.333 | Iran |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 254 | CTG - CCG | 85 | Leu - Pro | -5.939 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | Iran |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 104 | CTG - CCG | 35 | Leu - Pro | -5.282 | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 104 | CTG - CCG | 35 | Leu - Pro | -5.282 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 254 | CTG - CGG | 85 | Leu - Arg | -5.156 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 539 | GTC - GGC | 180 | Val - Gly | -5.071 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | Iran |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - GCC | 47 | Thr - Ala | -4.523 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 478 | ACA - GCA | 160 | Thr - Ala | -4.48 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 398 | ATT - ACT | 133 | Ile - Thr | -4.447 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 286 | AAG - GAG | 96 | Lys - Glu | -3.947 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 137 | GCA - GTA | 46 | Ala - Val | -3.856 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 36 | GAC - GAA | 12 | Asp - Glu | -3.84 | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 389 | GTG - GCG | 130 | Val - Ala | -3.701 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 28 | CAG - GAG | 10 | Gln - Glu | -2.879 | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 3 | ATG - ATA | 1 | Met - Ile | -1.916 | Iran |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 16 | ATC - CTC | 6 | Ile - Leu | -1.858 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 195 | TCC - TCT | 65 | Ser - Ser | 0 | Iran |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 192 | TAT - TAG | 64 | Tyr - Stop | NA | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 309 | TAC - TAG | 103 | Tyr - Stop | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 364 | CAA - TAA | 122 | Gln - Stop | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 421 | CAG - TAG | 141 | Gln - Stop | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 561 | TGA - TGG | 187 | Stop - Trp | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 45 | G - Insertion | NA | NA | NA | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 48 | G - Insertion | NA | NA | NA | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 440 | G - Insertion | NA | NA | NA | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 280 | GT - Insertion | NA | NA | NA | Australia and Papua New Guinea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 392 | G - Insertion | NA | NA | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 134 | A - Deletion | NA | NA | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 388 - 396 | GTGGTCGGT - Deletion | 130 - 132 | Val Val Gly - Deletion | -23.866 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 382 | GTCGATGTG - Deletion | 128 - 130 | Val Asp Val - Deletion | -22.813 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 271 - 273 | GAG - Deletion | 91 | Glu - Deletion | -14.003 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 68 | Trp - Arg | -13.64 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 68 | Trp - Arg | -13.64 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 68 | Trp - Arg | -13.64 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 68 | Trp - Arg | -13.64 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 68 | Trp - Arg | -13.64 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 68 | Trp - Arg | -13.64 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 68 | Trp - Arg | -13.64 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 68 | Trp - Arg | -13.64 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - AGG | 68 | Trp - Arg | -13.64 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 203 | TGG - TCG | 68 | Trp - Ser | -13.629 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 203 | TGG - TCG | 68 | Trp - Ser | -13.629 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 203 | TGG - TCG | 68 | Trp - Ser | -13.629 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 355 | TGG - CGG | 119 | Trp - Arg | -13.602 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - GGG | 68 | Trp - Gly | -12.665 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 204 | TGG - TGT | 68 | Trp - Cys | -12.649 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 203 | TGG - TTG | 68 | Trp - Leu | -12.633 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 356 | TGG - TTG | 119 | Trp - Leu | -12.56 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 357 | TGG - TGC | 119 | Trp - Cys | -12.396 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 357 | TGG - TGT | 119 | Trp - Cys | -12.396 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 357 | TGG - TGT | 119 | Trp - Cys | -12.396 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 214 | TGC - CGC | 72 | Cys - Arg | -11.8 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 214 | TGC - CGC | 72 | Cys - Arg | -11.8 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - Arg | -11.52 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - Arg | -11.52 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - Arg | -11.52 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - Arg | -11.52 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - Arg | -11.52 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - Arg | -11.52 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - Arg | -11.52 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - Arg | -11.52 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | TGC - CGC | 14 | Cys - Arg | -11.52 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 412 | TGT - CGT | 138 | Cys - Arg | -11.179 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 412 | TGT - CGT | 138 | Cys - Arg | -11.179 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 412 | TGT - GGT | 138 | Cys - Gly | -11.159 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 215 | TGC - TAC | 72 | Cys - Tyr | -10.817 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 215 | TGC - TAC | 72 | Cys - Tyr | -10.817 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 215 | TGC - TAC | 72 | Cys - Tyr | -10.817 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 41 | TGC - TAC | 14 | Cys - Tyr | -10.56 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 41 | TGC - TAC | 14 | Cys - Tyr | -10.56 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 364 - 366 | CAA - Deletion | 122 | Gln - Deletion | -10.371 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 413 | TGT - TAT | 138 | Cys - Tyr | -10.234 | Colorado in United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 413 | TGT - TAT | 138 | Cys - Tyr | -10.234 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 413 | TGT - TAT | 138 | Cys - Tyr | -10.234 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 413 | TGT - TAT | 138 | Cys - Tyr | -10.234 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 280 | TTC - CCC | 94 | Phe - Pro | -9.836 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 212 | CAT - CCT | 71 | His - Pro | -9.833 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 206 | CCG - CTG | 69 | Pro - Leu | -9.745 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 206 | CCA - CTA | 69 | Pro - Leu | -9.745 | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 307 | TAC - GAC | 103 | Tyr - Asp | -9.72 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CCC | 51 | His - Pro | -9.662 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CCC | 51 | His - Pro | -9.662 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CCC | 51 | His - Pro | -9.662 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CCC | 51 | His - Pro | -9.662 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CCC | 51 | His - Pro | -9.662 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CCC | 51 | His - Pro | -9.662 | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 170 | CAC - CCC | 57 | His - Pro | -9.661 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 170 | CAC - CCC | 57 | His - Pro | -9.661 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 171 | CAC - CCT | 57 | His - Pro | -9.661 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 170 | CAC - CCC | 57 | His - Pro | -9.661 | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 170 | CAC - CCC | 57 | His - Pro | -9.661 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CTG | 62 | Pro - Leu | -9.657 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CTG | 62 | Pro - Leu | -9.657 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CTG | 62 | Pro - Leu | -9.657 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 160 | CCG - CTG | 54 | Pro - Leu | -9.651 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 246 | CAT - CTT | 82 | His - Leu | -9.563 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 413 | TGT - TCT | 138 | Cys - Ser | -9.313 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 412 | TGT - AGT | 138 | Cys - Ser | -9.313 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 331 - 333 | GAG - Deletion | 111 | Glu - Deletion | -9.201 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 289 | GGT - TGT | 97 | Gly - Cys | -8.874 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 232 | GGC - TGC | 78 | Gly - Cys | -8.858 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 212 | CAT - GAT | 71 | His - Asp | -8.85 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 211 | CAT - GAT | 71 | His - Asp | -8.85 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 206 | CCA - CGA | 69 | Pro - Arg | -8.77 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 308 | TAC - TGC | 103 | Tyr - Arg | -8.753 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 248 | CCC - CGC | 83 | Pro - Arg | -8.75 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 314 | GGC - GTC | 105 | Gly - Val | -8.733 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 308 | TAC - TGC | 103 | Tyr - Cys | -8.727 | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 308 | TAC - TGC | 103 | Tyr - Cys | -8.727 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 308 | TAC - TCC | 103 | Tyr - Ser | -8.72 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 308 | TAC - TCC | 103 | Tyr - Ser | -8.72 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 151 | CAC - GAC | 51 | His - Asp | -8.696 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CAG | 62 | Pro - His | -8.695 | Azerbaijan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CGG | 62 | Pro - Arg | -8.693 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - GAC | 57 | His - Asp | -8.69 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - GAC | 57 | His - Asp | -8.69 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - GAC | 57 | His - Asp | -8.69 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - GAC | 57 | His - Asp | -8.69 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - GAC | 57 | His - Asp | -8.69 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - GAC | 57 | His - Asp | -8.69 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - GAC | 57 | His - Asp | -8.69 | United Kingdom |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 146 | GAC - GTC | 49 | Asp - Val | -8.683 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 145 | GAC - TAC | 49 | Asp - Tyr | -8.681 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 22 | GAC - TAC | 8 | Asp - Tyr | -8.64 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 22 | GAC - TAC | 8 | Asp - Tyr | -8.64 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 22 | GAC - TAC | 8 | Asp - Tyr | -8.64 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 22 | GAC - TAC | 8 | Asp - Tyr | -8.64 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 34 | GAC - TAC | 12 | Asp - Tyr | -8.64 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 410 | CAT - CTT | 137 | His - Leu | -8.474 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 406 | GAT - TAT | 136 | Asp - Tyr | -8.385 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 430 | GAG - Deletion | 144 | Glu - Deletion | -8.37 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 410 | CAT - CCT | 137 | His - Pro | -8.164 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 410 | CAT - CCT | 137 | His - Pro | -8.164 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 410 | CAT - CCT | 137 | His - Pro | -8.164 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 410 | CAT - CCT | 137 | His - Pro | -8.164 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 244 | CAT - GAT | 82 | His - Asp | -8.111 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 244 | CAT - TAT | 82 | His - Asp | -8.111 | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 68 - 69 | GGT - GTC | 23 | Gly - Val | -8.086 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 190 | TAT - GAT | 64 | Tyr - Asp | -8.021 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 212 | CAT - CGT | 71 | His - Arg | -7.867 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 212 | CAT - CGT | 71 | His - Arg | -7.867 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 212 | CAT - CGT | 71 | His - Arg | -7.867 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 213 | CAT - CAA | 71 | His - Gln | -7.867 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 213 | CAT - CAG | 71 | His - Gln | -7.867 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 212 | CAT - CGT | 71 | His - Arg | -7.867 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 212 | CAT - CGT | 71 | His - Arg | -7.867 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 213 | CAT - CAA | 71 | His - Gln | -7.867 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 213 | CAT - CAG | 71 | His - Glu | -7.867 | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 212 | CAT - CGT | 71 | His - Arg | -7.867 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 281 | TTC - TCC | 94 | Phe - Ser | -7.863 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 289 | GGT - CGT | 97 | Gly - Arg | -7.842 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 289 | GGT - CGT | 97 | Gly - Arg | -7.842 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 281 | TTC - TGC | 94 | Phe - Cys | -7.816 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 205 | CCA - TCA | 69 | Pro - Ser | -7.776 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 128 | CAC - CCC | 43 | His - Pro | -7.773 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 485 | GGT - GTT | 162 | Gly - Val | -7.771 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 347 | CTG - CAG | 116 | Leu - Gly | -7.753 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 173 | TTC - TCC | 58 | Phe - Ser | -7.732 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 173 | TTC - TCC | 58 | Phe - Ser | -7.732 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 173 | TTC - TCC | 58 | Phe - Ser | -7.732 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 170 | CAC - CGC | 57 | His - Arg | -7.729 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 153 | CAC - CAG | 51 | His - Gln | -7.728 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 153 | CAC - CAA | 51 | His - Gln | -7.728 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 153 | CAC - CAA | 51 | His - Gln | -7.728 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 153 | CAC - CAG | 51 | His - Gln | -7.728 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 153 | CAC - CAA | 51 | His - Gln | -7.728 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 184 | CCG - ACG | 62 | Pro - Thr | -7.727 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 184 | CCG - ACG | 62 | Pro - Thr | -7.727 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 184 | CCG - TCG | 62 | Pro - Ser | -7.727 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 151 | CAC - CGC | 51 | His - Arg | -7.726 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CGC | 51 | His - Arg | -7.726 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CGC | 51 | His - Arg | -7.726 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CGC | 51 | His - Arg | -7.726 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 152 | CAC - CGC | 51 | His - Arg | -7.726 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 188 | GAC - GCC | 63 | Asp - Ala | -7.725 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 188 | GAC - GCC | 63 | Asp - Ala | -7.725 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 188 | GAC - GCC | 63 | Asp - Ala | -7.725 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CAG | 62 | Pro - Gln | -7.724 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CAG | 62 | Pro - Gln | -7.724 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CAG | 62 | Pro - Gln | -7.724 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 185 | CCG - CAG | 62 | Pro - Gln | -7.724 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 160 | CCG - TCG | 54 | Pro - Ser | -7.723 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 160 | CCG - TCG | 54 | Pro - Ser | -7.723 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 160 | CCG - ACG | 54 | Pro - Thr | -7.722 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CAG | 54 | Pro - Gln | -7.721 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 146 | GAC - GCC | 49 | Asp - Ala | -7.717 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 146 | GAC - GCC | 49 | Asp - Ala | -7.717 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 146 | GAC - GCC | 49 | Asp - Ala | -7.717 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 146 | GAC - GCC | 49 | Asp - Ala | -7.717 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 146 | GAC - GCC | 49 | Asp - Ala | -7.717 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 23 | GAC - GCC | 8 | Asp - Ala | -7.68 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 35 | GAC - GCC | 12 | Asp - Ala | -7.68 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 35 | "GAC - GC C" | 12 | Asp - Ala | -7.68 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 35 | GAC - GCC | 12 | Asp - Ala | -7.68 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 35 | GAC - GCC | 12 | Asp - Ala | -7.68 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 38 | TTC - TCC | 13 | Phe - Ser | -7.68 | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 322 | GGA - CGA | 108 | Gly - Arg | -7.478 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 246 | CAT - CAA | 82 | His - Gln | -7.107 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 245 | CAT - CGT | 82 | His - Arg | -6.982 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 245 | CAT - CGT | 82 | His - Arg | -6.982 | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 245 - 246 | CAT - CGG | 82 | His - Arg | -6.982 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 70 | GGC - CGC | 24 | Gly - Arg | -6.976 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 223 | GGT - CGT | 75 | Gly - Arg | -6.937 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 290 | GGT - GAT | 97 | Gly - Asp | -6.903 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 290 | GGT - GAT | 97 | Gly - Asp | -6.903 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 290 | GGT - GAT | 97 | Gly - Asp | -6.903 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 290 | GGT - GAT | 97 | Gly - Asp | -6.903 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 290 | GGT - GAT | 97 | Gly - Asp | -6.903 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 290 | GGT - GAT | 97 | Gly - Asp | -6.903 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 290 | GGT - GAT | 97 | Gly - Asp | -6.903 | United Kingdom |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 232 | GGC - AGC | 78 | Gly - Asp | -6.875 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 233 | GGC - GAC | 78 | Gly - Asp | -6.875 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 314 | GGC - GAC | 105 | Gly - Asp | -6.787 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 314 | GGC - GAC | 105 | Gly - Asp | -6.787 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 347 | CTG - CCG | 116 | Leu - Pro | -6.782 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 172 | TTC - GTC | 58 | Phe - Val | -6.767 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 187 | GAC - CAC | 63 | Asp - His | -6.767 | Colorado in United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 188 | GAC - GGC | 63 | Asp - Gly | -6.767 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 188 | GAC - GGC | 63 | Asp - Gly | -6.767 | Yemen |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 151 | CAC - AAC | 51 | His - Asn | -6.763 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 146 | GAC - GGC | 49 | Asp - Gly | -6.749 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 146 | GAC - GGC | 49 | Asp - Gly | -6.749 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 146 | GAC - GGC | 49 | Asp - Gly | -6.749 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 145 | GAC - CAC | 49 | Asp - His | -6.746 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 23 | GAC - GGC | 8 | Asp - Gly | -6.72 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 8 | GAC - CAC | 8 | Asp - His | -6.72 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 35 | GAC - GGC | 12 | Asp - Gly | -6.72 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 37 | TTC - GTC | 13 | Phe - Val | -6.72 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 50 | GGC - GAC | 17 | Gly - Asp | -6.72 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 384 | GTC - GGC | 128 | Val - Gly | -6.591 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 383 | GTC - GGC | 128 | Val - Gly | -6.591 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 383 | GTC - GGC | 128 | Val - Gly | -6.591 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 383 | GTC - GGC | 128 | Val - Gly | -6.591 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 359 | CTG - CCG | 120 | Leu - Pro | -6.563 | Portugal |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 359 | CTG - CCG | 120 | Leu - Pro | -6.563 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 359 | CTG - CCG | 120 | Leu - Pro | -6.563 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 359 | CTG - CCG | 120 | Leu - Pro | -6.563 | United Kingdom |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 410 | CAT - CGT | 137 | His - Arg | -6.559 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 410 | CAT - CGT | 137 | His - Arg | -6.559 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 410 | CAT - CGT | 137 | His - Arg | -6.559 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 26 | GTG - GGG | 9 | Val - Gly | -6.553 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 26 | GTG - GGG | 9 | Val - Gly | -6.553 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 374 | GTC - GGC | 125 | Val - Gly | -6.553 | Portugal |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 158 | GAC - GCC | 53 | Asp - Ala | -6.536 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 407 | GAT - GGT | 136 | Asp - Gly | -6.525 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 407 | GAT - GGT | 136 | Asp - Gly | -6.525 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 407 | GAT - GGT | 136 | Asp - Gly | -6.525 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 20 | GTC - GGC | 7 | Val - Gly | -6.524 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 20 | GTC - GGC | 7 | Val - Gly | -6.524 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 20 | GTC - GGC | 7 | Val - Gly | -6.524 | Yemen |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 20 | GTC - GGC | 7 | Val - Gly | -6.524 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 389 | GTG - GGG | 130 | Val - Gly | -6.524 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 389 | GTG - GGG | 130 | Val - Gly | -6.524 | Canada |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 389 | GTG - GGG | 130 | Val - Gly | -6.524 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 395 | GGT - GAT | 132 | Gly - Asp | -6.523 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 395 | GGT - GAT | 132 | Gly - Asp | -6.523 | Myanmar |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 395 | GGT - GAT | 132 | Gly - Asp | -6.523 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 406 | GAT - CAT | 136 | Asp - His | -6.519 | Scotland |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GGG | 139 | Val - Gly | -6.511 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GGG | 139 | Val - Gly | -6.511 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GGG | 139 | Val - Gly | -6.511 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GGG | 139 | Val - Gly | -6.511 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GGG | 139 | Val - Gly | -6.511 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GGG | 139 | Val - Gly | -6.511 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GGG | 139 | Val - Gly | -6.511 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 56 | CTG - CCG | 19 | Leu - Pro | -6.508 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 56 | CTG - CCG | 19 | Leu - Pro | -6.508 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 241 | TTC - GTC | 81 | Phe - Val | -6.489 | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 241 | TTC - GTC | 81 | Phe - Val | -6.489 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 134 | GTG - GGG | 45 | Val - Gly | -6.487 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 134 | GTG - GGG | 45 | Val - Gly | -6.487 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 20 | GTC - GAC | 7 | Val - Asp | -6.486 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 464 | GTG - GGG | 155 | Val - Gly | -6.453 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 464 | GTG - GGG | 155 | Val - Gly | -6.453 | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 464 | GTG - GGG | 155 | Val - Gly | -6.453 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 464 | GTG - GGG | 155 | Val - Gly | -6.453 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 464 | GTG - GGG | 155 | Val - Gly | -6.453 | United Kingdom |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 4 | CGG - TGG | 2 | Arg - Trp | -6.417 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 398 | ATT - AAT | 133 | Ile - Asn | -6.387 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 374 | GTC - GAC | 125 | Val - Asp | -6.304 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 374 | GTC - GAC | 125 | Val - Asp | -6.304 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 71 | GGC - GAC | 24 | Gly - Asp | -6.212 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 71 | GGC - GAC | 24 | Gly - Asp | -6.212 | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 71 | GGC - GAC | 24 | Gly - Asp | -6.212 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 485 | GGT - GAT | 162 | Gly - Asp | -6.179 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 485 | GGT - GAT | 162 | Gly - Asp | -6.179 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 62 | GTA - GGA | 21 | Val - Gly | -6.17 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 467 | CTG - CCG | 156 | Leu - Pro | -6.08 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 467 | CTG - CCG | 156 | Leu - Pro | -6.08 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 467 | CTG - CCG | 156 | Leu - Pro | -6.08 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 476 | CTG - CCG | 159 | Leu - Pro | -6.041 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 476 | CTG - CCG | 159 | Leu - Pro | -6.041 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 254 | CTG - CCG | 85 | Leu - Pro | -5.939 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 254 | CTG - CCG | 85 | Leu - Pro | -5.939 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 254 | CTG - CCG | 85 | Leu - Pro | -5.939 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 287 | AAG - ATG | 96 | Lys - Met | -5.92 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 287 | AAG - ATG | 96 | Lys - Met | -5.92 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 289 | GGT - AGT | 97 | Gly - Ser | -5.909 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 289 | GGT - AGT | 97 | Gly - Ser | -5.909 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 289 | GGT - AGT | 97 | Gly - Ser | -5.909 | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 282 | TTC - TTG | 94 | Phe - Leu | -5.907 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 280 | TTC - CTC | 94 | Phe - Leu | -5.907 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 211 | CAT - TAT | 71 | His - Tyr | -5.9 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 211 | CAT - TAT | 71 | His - Tyr | -5.9 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 211 | CAT - TAT | 71 | His - Tyr | -5.9 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 211 | CAT - TAT | 71 | His - Tyr | -5.9 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 211 | CAT - TAT | 71 | His - Tyr | -5.9 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 287 | AAG - ACG | 96 | Lys - Thr | -5.88 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 287 | AAG - ACG | 96 | Lys - Thr | -5.88 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 347 | CTG - CGG | 116 | Leu - Arg | -5.828 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 347 | CTG - CGG | 116 | Leu - Arg | -5.828 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 347 | CTG - CGG | 116 | Leu - Arg | -5.828 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 174 | TTC - TTG | 58 | Phe - Leu | -5.8 | Canada |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 172 | TTC - CTC | 58 | Phe - Leu | -5.8 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 174 | TTC - TTG | 58 | Phe - Leu | -5.8 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 172 | TTC - CTC | 58 | Phe - Leu | -5.8 | Peru |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 174 | TTC - TTA | 58 | Phe - Leu | -5.8 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 151 | CAC - TAC | 51 | His - Tyr | -5.798 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 151 | CAC - TAC | 51 | His - Tyr | -5.798 | Scotland |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 151 | CAC - TAC | 51 | His - Tyr | -5.798 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - TAC | 57 | His - Tyr | -5.798 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - TAC | 57 | His - Tyr | -5.798 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - TAC | 57 | His - Tyr | -5.798 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - TAC | 57 | His - Tyr | -5.798 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - TAC | 57 | His - Tyr | -5.798 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 169 | CAC - TAC | 57 | His - Tyr | -5.798 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 37 | TTC - CTC | 13 | Phe - Leu | -5.76 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 46 | GGT - AGT | 16 | Gly - Ser | -5.76 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 50 | GGC - GCC | 17 | Gly - Ala | -5.76 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | Myanmar |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCA | 10 | Gln - Pro | -5.758 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 83 | GCC - GAC | 28 | Ala - Asp | -5.66 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 56 | CTG - CGG | 19 | Leu - Arg | -5.654 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 362 | CGG - CCG | 121 | Arg - Pro | -5.648 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 362 | CGG - CCG | 121 | Arg - Pro | -5.648 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | Canada |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | CTG - CCG | 172 | Leu - Pro | -5.635 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 140 | ACC - ATC | 47 | Thr - Ile | -5.627 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - CCC | 47 | Thr - Pro | -5.625 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - CCC | 47 | Thr - Pro | -5.625 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 92 | ATC - AGC | 31 | Ile - Ser | -5.614 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 92 | ATC - AGC | 31 | Ile - Ser | -5.614 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - ATG | 142 | Thr - Met | -5.601 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - ATG | 142 | Thr - Met | -5.601 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - AAG | 142 | Thr - Lys | -5.601 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - ATG | 142 | Thr - Met | -5.601 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - AAG | 142 | Thr - Lys | -5.601 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - ATG | 142 | Thr - Met | -5.601 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - ATG | 142 | Thr - Met | -5.601 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - ATG | 142 | Thr - Met | -5.601 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - ATG | 142 | Thr - Met | -5.601 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - ATG | 142 | Thr - Met | -5.601 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 425 | ACG - AGG | 142 | Thr - Arg | -5.6 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 424 | ACG - CCG | 142 | Thr - Pro | -5.596 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 424 | ACG - CCG | 142 | Thr - Pro | -5.596 | Peru |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 11 | TTG - TGG | 4 | Leu - Trp | -5.595 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 11 | TTG - TGG | 4 | Leu - Trp | -5.595 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 11 | TTG - TGG | 4 | Leu - Trp | -5.595 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 134 | GTG - GAG | 45 | Val - Glu | -5.593 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 11 | TTG - TCG | 4 | Leu - Ser | -5.591 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 11 | TTG - TCG | 4 | Leu - Ser | -5.591 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 11 | TTG - TCG | 4 | Leu - Ser | -5.591 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 11 | TTG - TCG | 4 | Leu - Ser | -5.591 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 394 - 395 | GGT - TCT | 132 | Gly - Ser | -5.572 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 394 | GGT - AGT | 132 | Gly - Ser | -5.572 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 394 | GGT - AGT | 132 | Gly - Ser | -5.572 | Pakistan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 394 | GGT - AGT | 132 | Gly - Ser | -5.572 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 394 | GGT - AGT | 132 | Gly - Ser | -5.572 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 460 | AGG - GGG | 154 | Arg - Gly | -5.57 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 460 | AGG - GGG | 154 | Arg - Gly | -5.57 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 460 | AGG - GGG | 154 | Arg - Gly | -5.57 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 460 | AGG - GGG | 154 | Arg - Gly | -5.57 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 460 | AGG - GGG | 154 | Arg - Gly | -5.57 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 460 | AGG - GGG | 154 | Arg - Gly | -5.57 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 395 | GGT - GCT | 132 | Gly - Ala | -5.564 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 395 | GGT - GCT | 132 | Gly - Ala | -5.564 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 395 | GGT - GCT | 132 | Gly - Ala | -5.564 | United Kingdom |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 359 | CTG - CGG | 120 | Leu - Arg | -5.552 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | ACC - CCC | 135 | Thr - Pro | -5.504 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | ACC - CCC | 135 | Thr - Pro | -5.504 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | ACC - CCC | 135 | Thr - Pro | -5.504 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | ACC - CCC | 135 | Thr - Pro | -5.504 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | ACC - CCC | 135 | Thr - Pro | -5.504 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | ACC - CCC | 135 | Thr - Pro | -5.504 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | ACC - CCC | 135 | Thr - Pro | -5.504 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 479 | ACA - AAA | 160 | Thr - Lys | -5.444 | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 478 | ACA - CCA | 160 | Thr - Pro | -5.441 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 478 | ACA - CCA | 160 | Thr - Pro | -5.441 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 100 | TAC - GAC | 34 | Tyr - Asp | -5.411 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 100 | TAC - GAC | 34 | Tyr - Asp | -5.411 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 100 | TAC - GAC | 34 | Tyr - Asp | -5.411 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 68 | GGT - GCT | 23 | Gly - Ala | -5.331 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 17 | ATC - AGC | 6 | Ile - Ser | -5.291 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 104 | CTG - CCG | 35 | Leu - Pro | -5.282 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 104 | CTG - CGG | 35 | Leu - Pro | -5.282 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 104 | CTG - CCG | 35 | Leu - Pro | -5.282 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 104 | CTG - CCG | 35 | Leu - Pro | -5.282 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 176 | TCC - TTC | 59 | Ser - Phe | -5.262 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 227 | ACT - ATT | 76 | Thr - Ile | -5.173 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 227 | ACT - ATT | 76 | Thr - Ile | -5.173 | United Kindom and Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 227 | ACT - ATT | 76 | Thr - Ile | -5.173 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 368 | CGC - CCC | 123 | Arg - Pro | -5.173 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 368 | CGC - CCC | 123 | Arg - Pro | -5.173 | United Kingdom |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 254 | CTG - CGG | 85 | Leu - Arg | -5.156 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 254 | CTG - CGG | 85 | Leu - Arg | -5.156 | Azerbaijan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 254 | CTG - CGG | 85 | Leu - Arg | -5.156 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 476 | CTG - CGG | 159 | Leu - Arg | -5.144 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 476 | CTG - CGG | 159 | Leu - Arg | -5.144 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 484 | GGT - AGT | 162 | Gly - Ser | -5.115 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 269 | ATC - AGC | 90 | Ile - Ser | -5.047 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 269 | ATC - AGC | 90 | Ile - Ser | -5.047 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 269 | ATC - AGC | 90 | Ile - Ser | -5.047 | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - CCT | 76 | Thr - Pro | -4.975 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 288 | AAG - AAC | 96 | Lys - Asn | -4.927 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 288 | AAG - AAC | 96 | Lys - Asn | -4.927 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 136 | GCA - CCA | 46 | Ala - Pro | -4.833 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 137 | GCA - GAA | 46 | Ala - Glu | -4.833 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 137 | GCA - GAA | 46 | Ala - Glu | -4.833 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 307 | TAC - CAC | 103 | Tyr - His | -4.833 | Canada |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 307 | TAC - CAC | 103 | Tyr - His | -4.833 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 307 | TAC - CAC | 103 | Tyr - His | -4.833 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 307 | TAC - CAC | 103 | Tyr - His | -4.833 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 307 | TAC - CAC | 103 | Tyr - His | -4.833 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 312 | AGC - AGG | 104 | Ser - Arg | -4.833 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 312 | AGC - AGG | 104 | Ser - Arg | -4.833 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 312 | AGC - AGA | 104 | Ser - Arg | -4.833 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 312 | AGC - AGG | 104 | Ser - Arg | -4.833 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 312 | AGC - AGA | 104 | Ser - Arg | -4.833 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 312 | AGC - AGG | 104 | Ser - Arg | -4.833 | Yemen |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 312 | NA | 104 | Ser - Arg | -4.833 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 145 | GAC - AAC | 49 | Asp - Asn | -4.806 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 22 | GAC - AAC | 8 | Asp - Asn | -4.8 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 22 | GAC - AAC | 8 | Asp - Asn | -4.8 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 34 | GAC - AAC | 12 | Asp - Asn | -4.8 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 34 | GAC - AAC | 12 | Asp - Asn | -4.8 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 167 | GAC - GGC | 56 | Asp - Cys | -4.741 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 458 | ACC - ATC | 153 | Thr - Ile | -4.697 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 458 | ACC - ATC | 153 | Thr - Ile | -4.697 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 418 | CGC - AGC | 140 | Arg - Ser | -4.683 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 19 | GTC - TTC | 7 | Val - Phe | -4.681 | Peru |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 19 | GTC - TTC | 7 | Val - Phe | -4.681 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 424 | ACG - GCG | 142 | Thr - Ala | -4.67 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 424 | ACG - GCG | 142 | Thr - Ala | -4.67 | Myanmar |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 424 | ACG - GCG | 142 | Thr - Ala | -4.67 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 424 | ACG - GCG | 142 | Thr - Ala | -4.67 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 406 | GAT - AAT | 136 | Asp - Asn | -4.644 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 481 | GCG - CCG | 161 | Ala - Pro | -4.63 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 502 | ACC - CCC | 168 | Thr - Pro | -4.63 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 502 | ACC - CCC | 168 | Thr - Pro | -4.63 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 502 | ACC - CCC | 168 | Thr - Pro | -4.63 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 340 | ACG - CCG | 114 | Thr - Pro | -4.626 | Yemen |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 7 | GCG - CCG | 3 | Ala - Pro | -4.578 | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 8 | GCG - GAG | 3 | Ala - Glu | -4.578 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 8 | GCG - GAG | 3 | Ala - Glu | -4.578 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 8 | GCG - GAG | 3 | Ala - Glu | -4.578 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | ACC - GCC | 135 | Thr - Ala | -4.576 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | ACC - GCC | 135 | Thr - Ala | -4.576 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 436 | GCG - CCG | 146 | Ala - Pro | -4.572 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 437 | GCG - GAG | 146 | Ala - Glu | -4.564 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 92 | ATC - ACC | 31 | Ile - Thr | -4.549 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 92 | ATC - ACC | 31 | Ile - Thr | -4.549 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 512 | GCG - GAG | 171 | Ala - Glu | -4.53 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 512 | GCG - GAG | 171 | Ala - Glu | -4.53 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 171 | GCG - GAG | 171 | Ala - Glu | -4.53 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - GCC | 47 | Thr - Ala | -4.523 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - GCC | 47 | Thr - Ala | -4.523 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - GCC | 47 | Thr - Ala | -4.523 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - GCC | 47 | Thr - Ala | -4.523 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - GCC | 47 | Thr - Ala | -4.523 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - GCC | 47 | Thr - Ala | -4.523 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 199 | TCG - CCG | 67 | Ser - Pro | -4.512 | Canada |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 199 | TCG - CCG | 67 | Ser - Pro | -4.512 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 199 | TCG - CCG | 67 | Ser - Pro | -4.512 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 199 | TCG - CCG | 67 | Ser - Pro | -4.512 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 199 | TCG - CCG | 67 | Ser - Pro | -4.512 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 199 | TCG - CCG | 67 | Ser - Pro | -4.512 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 199 | TCG - CCG | 67 | Ser - Pro | -4.512 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 199 | TCG - CCG | 67 | Ser - Pro | -4.512 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 470 | GTG - GGG | 157 | Val - Gly | -4.452 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 470 | GTG - GGG | 157 | Val - Gly | -4.452 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 398 | ATT - ACT | 133 | Ile - Thr | -4.447 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 398 | ATT - ACT | 133 | Ile - Thr | -4.447 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 511 | GCG - CCG | 171 | Ala - Pro | -4.401 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 511 | GCG - CCG | 171 | Ala - Pro | -4.401 | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 14 | ATC - ACC | 5 | Ile - Thr | -4.355 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 458 | ACC - AAC | 153 | Thr - Asn | -4.339 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 458 | ACC - AAC | 153 | Thr - Asn | -4.339 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 104 | CTG - CGG | 35 | Leu - Arg | -4.294 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 104 | CTG - CGG | 35 | Leu - Arg | -4.294 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 104 | CTG - CGG | 35 | Leu - Arg | -4.294 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 104 | CTG - CGG | 35 | Leu - Arg | -4.294 | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 461 | AGG - ACG | 154 | Arg - Thr | -4.294 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 461 | AGG - ACG | 154 | Arg - Thr | -4.294 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 175 | TCC - CCC | 59 | Ser - Pro | -4.286 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 175 | TCC - CCC | 59 | Ser - Pro | -4.286 | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 175 | TCC - CCC | 59 | Ser - Pro | -4.286 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 175 | TCC - CCC | 59 | Ser - Pro | -4.286 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 101 | TAC - TCC | 34 | Tyr - Ser | -4.279 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 373 | GTC - TTC | 125 | Val - Phe | -4.267 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 373 | GTC - TTC | 125 | Val - Phe | -4.267 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 538 | GTC - TTC | 180 | Val - Phe | -4.266 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 538 | GTC - TTC | 180 | Val - Phe | -4.266 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 538 | GTC - TTC | 180 | Val - Phe | -4.266 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 538 | GTC - TTC | 180 | Val - Phe | -4.266 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 52 | TCG - CCG | 18 | Ser - Pro | -4.241 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 524 - 525 | ATG - AGA | 175 | Met - Arg | -4.24 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 503 | ACC - AAC | 168 | Thr - Asn | -4.085 | Canada |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 499 | ACC - CCC | 167 | Thr - Pro | -4.063 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 17 | ATC - ACC | 6 | Ile - Thr | -3.987 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 17 | ATC - ACC | 6 | Ile - Thr | -3.987 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 545 | TTG - TCG | 182 | Leu - Ser | -3.97 | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 545 | TTG - TCG | 182 | Leu - Ser | -3.97 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 286 | AAG - GAG | 96 | Lys - Glu | -3.947 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 286 | AAG - CAG | 96 | Lys - Gln | -3.947 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 286 | AAG - GAG | 96 | Lys - Gln | -3.947 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 286 | AAG - CAG | 96 | Lys - Gln | -3.947 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 286 | AAG - GAG | 96 | Lys - Glu | -3.947 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 286 | AAG - GAG | 96 | Lys - Glu | -3.947 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 286 | AAG - CAG | 96 | Lys - Gln | -3.947 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 137 | GCA - GTA | 46 | Ala - Val | -3.856 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 137 | GCA - GTA | 46 | Ala - Val | -3.856 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 137 | GCA - GTA | 46 | Ala - Val | -3.856 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 147 | GAC - GAG | 49 | Asp - Glu | -3.856 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 147 | GAC - GAG | 49 | Asp - Glu | -3.856 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 24 | GAC - GAG | 8 | Asp - Glu | -3.84 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 36 | GAC - GAG | 12 | Asp - Glu | -3.84 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 28 | CAG - AAG | 10 | Gln - Lys | -3.837 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 28 | CAA - AAA | 10 | Gln - Lys | -3.837 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CGA | 10 | Gln - Arg | -3.835 | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CGG | 10 | Gln - Arg | -3.835 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 80 | CTG - CGG | 27 | Leu - Arg | -3.835 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 514 - 515 | CTG - GCG | 172 | Leu - Ala | -3.833 | Belgium |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 305 | GCG - GTG | 102 | Ala - Val | -3.789 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 305 | GCG - GTG | 102 | Ala - Val | -3.789 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 305 | GCG - GTG | 102 | Ala - Val | -3.789 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 319 | GAA - AAA | 107 | Glu - Lys | -3.756 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 401 | GCC - GTC | 134 | Ala - Val | -3.756 | Peru |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 401 | GCC - GTC | 134 | Ala - Val | -3.756 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 401 | GCC - GTC | 134 | Ala - Val | -3.756 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 442 | CGC - TGC | 148 | Arg - Cys | -3.754 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | ACT - GCT | 76 | Thr - Ala | -3.747 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 400 | GCC - ACC | 134 | Ala - Thr | -3.744 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GCG | 139 | Val - Ala | -3.712 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GCG | 139 | Val - Ala | -3.712 | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GCG | 139 | Val - Ala | -3.712 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GCG | 139 | Val - Ala | -3.712 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GCG | 139 | Val - Ala | -3.712 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GCG | 139 | Val - Ala | -3.712 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GCG | 139 | Val - Ala | -3.712 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 416 | GTG - GCG | 139 | Val - Ala | -3.712 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 82 | GCC - ACC | 28 | Ala - Thr | -3.707 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 82 | GCC - ACC | 28 | Ala - Thr | -3.707 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 389 | GTG - GCG | 130 | Val - Ala | -3.701 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 389 | GTG - GCG | 130 | Val - Ala | -3.701 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 20 | GTC - GCC | 7 | Val - Ala | -3.692 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | ACC - TCC | 47 | Thr - Ser | -3.685 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 26 | GTG - GCG | 9 | Val - Ala | -3.673 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 464 | GTG - GCG | 155 | Val - Ala | -3.669 | Peru |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 536 | AGC - ATC | 179 | Ser - Ile | -3.667 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 74 -75 | GCC - GAA | 25 | Ala - Glu | -3.652 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 436 | GCG - ACG | 146 | Ala - Thr | -3.628 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 436 | GCG - ACG | 146 | Ala - Thr | -3.628 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 436 | GCG - ACG | 146 | Ala - Thr | -3.628 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 304 | GCG - ACG | 102 | Ala - Thr | -3.618 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 437 | GCG - GTG | 146 | Ala - Val | -3.606 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 437 | GCG - GTG | 146 | Ala - Val | -3.606 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 437 | GCG - GTG | 146 | Ala - Val | -3.606 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 511 | GCG - ACG | 171 | Ala - Thr | -3.602 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 511 | GCG - ACG | 171 | Ala - Thr | -3.602 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 524 | ATG - ACG | 175 | Met - Thr | -3.596 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 512 | GCG - GTG | 171 | Ala - Val | -3.581 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 512 | GCG - GTG | 171 | Ala - Val | -3.581 | Scotland |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 83 | GCC - GTC | 28 | Ala - Val | -3.573 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 134 | GTG - GCG | 45 | Val - Ala | -3.573 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 134 | GTG - GCG | 45 | Val - Ala | -3.573 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 340 | ACG - GCG | 114 | Thr - Ala | -3.541 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 260 | ACG - ATG | 87 | Thr - Met | -3.484 | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 335 | AAC - ATC | 112 | Asn - Tyr | -3.396 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 335 | AAC - ATC | 112 | Asn - Tyr | -3.396 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 488 | GTG - GCG | 163 | Val - Ala | -3.356 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 521 | GAG - GGG | 174 | Glu - Gly | -3.311 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 89 | GCC - GAC | 30 | Ala - Asp | -3.276 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 80 | CTG - CCG | 27 | Leu - Pro | -3.201 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 80 | CTG - CCG | 27 | Leu - Pro | -3.201 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 490 | TCG - CCG | 164 | Ser - Pro | -2.985 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 452 | TTG - TCG | 151 | Leu - Ser | -2.928 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 346 | CTG - GTG | 116 | Leu - Val | -2.91 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 136 | GCA - TCA | 46 | Ala - Ser | -2.9 | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 236 | GCG - GTG | 79 | Ala - Val | -2.85 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 19 | GTC - CTC | 7 | Val - Leu | -2.806 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 19 | GTC - CTC | 7 | Val - Leu | -2.806 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 417 | GTG - CTG | 139 | Val - Leu | -2.798 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 415 | GTG - CTG | 139 | Val - Leu | -2.798 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 415 | GTG - CTG | 139 | Val - Leu | -2.798 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 415 | GTG - CTG | 139 | Val - Leu | -2.798 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 415 | GTG - ATG | 139 | Val - Met | -2.791 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 415 | GTG - ATG | 139 | Val - Met | -2.791 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 58 | GCG - ACG | 20 | Ala - Thr | -2.765 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 7 | GCG - TCG | 3 | Ala - Ser | -2.716 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 463 | GTG - ATG | 155 | Val - Met | -2.671 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 376 | GAT - AAT | 126 | Asp - Asn | -2.578 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 26 | GTG - TTG | 9 | Val - Leu | -2.311 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 142 | AAG - GAG | 48 | Lys - Glu | -2.275 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 142 | AAG - GAG | 48 | Lys - Glu | -2.275 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 98 | GAC - GCC | 33 | Asp - Ala | -2.216 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 196 | TCG - CCG | 66 | Ser - Pro | -2.208 | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 196 | TCG - CCG | 66 | Ser - Pro | -2.208 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 196 | TCG - CCG | 66 | Ser - Pro | -2.208 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 196 | TCG - CCG | 66 | Ser - Pro | -2.208 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 298 | ACC - CCC | 100 | Thr - Pro | -2.086 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 298 | ACC - CCC | 100 | Thr - Pro | -2.086 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 78 | GCG - GCC | 26 | Ala - Gly | -2.085 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 2 | ATG - AGG | 1 | Met - Arg | -2.001 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 535 | AGC - CGC | 179 | Ser - Arg | -1.933 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 3 | ATG - ATA | 1 | Met - Ile | -1.916 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 3 | ATG - ATT | 1 | Met - Ile | -1.916 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 3 | ATG - ATA | 1 | Met - Ile | -1.916 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 16 | ATC - CTC | 6 | Ile - Leu | -1.858 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 523 | ATG - GTG | 175 | Met - Val | -1.826 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 442 | C - A | 148 | Arg - Ser | -1.796 | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 455 | GCC - GGC | 152 | Ala - Gly | -1.651 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 181 | ACA - CCA | 61 | Thr - Pro | -1.634 | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 181 | ACA - CCA | 61 | Thr - Pro | -1.634 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 529 | ACC - CCC | 177 | Thr - Pro | -1.477 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 529 | ACC - CCC | 177 | Thr - Pro | -1.477 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 543 | GAG - GAT | 181 | Glu - Asp | -1.452 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -8 | 8 bp - Deletion | 1 | Met - Deletion | -1.369 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 2 | ATG - ACG | 1 | Met - Thr | -1.301 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 2 | ATG - ACG | 1 | Met - Thr | -1.301 | Portugal |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 2 | ATG - ACG | 1 | Met - Thr | -1.301 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 2 | ATG - ACG | 1 | Met - Thr | -1.301 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | NA | NA | 175 | Met - Ile | -1.226 | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | Pakistan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 422 | CAG - CCG | 141 | Gln - Pro | -1.031 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 541 | GAG - CAG | 181 | Glu - Gln | -1.005 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 19 | GTC - ATC | 7 | Val - Ile | -0.957 | Peru |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 554 | AGC - ACC | 185 | Ser - Thr | -0.629 | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 113 | GCG - GGG | 38 | Ala - Gly | -0.519 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 551 | TGC - TAC | 184 | Cys - Tyr | -0.433 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 298 | ACC - GCC | 100 | Thr - Ala | -0.082 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 108 | GCC - GCG | 36 | Ala - Ala | 0 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 117 | GCG - GCA | 39 | Ala - Ala | 0 | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 195 | TCC - TCT | 65 | Ser - Ser | 0 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 195 | TCC - TCT | 65 | Ser - Ser | 0 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 195 | TCC - TCT | 65 | Ser - Ser | 0 | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 195 | TCC - TCT | 65 | Ser - Ser | 0 | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 195 | TCC - TCT | 65 | Ser - Ser | 0 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 195 | TCC - TCT | 65 | Ser - Ser | 0 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 233 | GGC - GTC | 78 | Gly - Gly | 0 | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 142 | AAG - GAG | 48 | Lys - Arg | 0.261 | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 446 | AAT - AGT | 149 | Asn - Ser | 0.763 | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 506 | GTC - GCC | 169 | Val - Ala | 1.599 | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 28 | CAG - TAG | 10 | Gln - Stop | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 28 | CAG - TAG | 10 | Gln - Stop | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 28 | CAA - TAA | 10 | Gln - Stop | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 52 | GG - Insertion | 17 | NA | NA | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 70 | G - Deletion | 24 | NA | NA | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 84 | C - Deletion | 28 | NA | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 94 | TTC - GTC | 32 | Phe - Val | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 102 | TAC - TAG | 34 | Tyr - Stop | NA | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 102 | TAC - TAG | 34 | Tyr - Stop | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 109 - 110 | GGA - TAA | 37 | Glu - Stop | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 123 | TAC - TAG | 41 | Tyr - Stop | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 123 | TAC - TAG | 41 | Tyr - Stop | NA | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 123 | TAC - TAA | 41 | Tyr - Stop | NA | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 136 | G - Insertion | 46 | NA | NA | Yemen |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 158 | A - Deletion | 53 | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | C - Deletion | 54 | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 162 | G - Deletion | 54 | NA | NA | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 172 | T - Deletion | 58 | NA | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 192 | A - Insertion | 64 | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 203 | TGG - TCA | 68 | Trp - Stop | NA | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 205 | CCA - GCA | 69 | Pro - Ala | NA | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 216 | TGC - TGA | 72 | Cys - stop | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 221 | G - Insertion | 74 | NA | NA | United Kingdom |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 202 | TGG - CGG | 86 | Trp - Arg | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 285 | TAC - TAG | 95 | Tyr - Stop | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 285 | TAC - TAA | 95 | Tyr - Stop | NA | Portugal |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 285 | TAC - TAA | 95 | Tyr - Stop | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 286 | AAG - TAG | 96 | Lys - Stop | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 297 | TAC - TAG | 99 | Tyr - Stop | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 297 | TAC - TAG | 99 | Tyr - Stop | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 297 | TAC - TAA | 99 | Tyr - Stop | NA | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 309 | TAC - TAG | 103 | Tyr - Stop | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 309 | TAC - TAA | 103 | Tyr - Stop | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 309 | TAC - TAG | 103 | Tyr - Stop | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 309 | TAC - TAG | 103 | Tyr - Stop | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 309 | TAC - TAA | 103 | Tyr - Stop | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 309 | TAC - TAG | 103 | Tyr - Stop | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 103 | TAC - TAG | 103 | Tyr - Stop | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 309 | TAC - TAA | 103 | Tyr - Stop | NA | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | NA | NA | 103 | Tyr - Stop | NA | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 319 | GAA - AAA | 107 | Gly - Lys | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 319 | GAA - TAA | 107 | Glu - Stop | NA | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 322 | GGA - TGA | 108 | Gly - Stop | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 331 | GAG - TAG | 111 | Glu - Stop | NA | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 357 | TGG - TGA | 119 | Trp - Stop | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 357 | TGG - TGA | 119 | Trp - Stop | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 357 | TGG - TGA | 119 | Trp - Stop | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 364 | CAA - TAA | 122 | Gln - Stop | NA | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 379 | GAG - TAG | 127 | Glu - Stop | NA | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 388 | AGGTCGATG - Insertion | 130 | Val Glu Val Asp | NA | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 - 393 | GTC - Deletion | 131 | Val - Deletion | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 414 | TGT - TGA | 138 | Cys - Stop | NA | Pakistan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 421 | CAG - TAG | 141 | Gln - Stop | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 421 | CAG - TAG | 141 | Gln - Stop | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 421 | CAG - TAG | 141 | Gln - Stop | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 474 | GAC - GAA | 159 | Asp - Glu | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 491 | TCG - TAG | 164 | Ser - Stop | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 523 | ATG - GTG | 174 | Met - Val | NA | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 541 | GAG - TAG | 181 | Glu - Stop | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 444 - 445 | Insertion | 148 - 149 | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 112 - 561 | Deletion | 37 - 187 | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 340 | A - Deletion | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 156 | T - Insertion | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 | GG - Insertion | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 450 | GC - Insertion | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 518 | G - Insertion | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 488 | G - Insertion | NA | NA | NA | Georgia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 558 | G - Deletion | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 392 | GG - Insertion | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 445 | GC - Insertion | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 445 | GC - Insertion | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 60 | G - Deletion | NA | NA | NA | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 218 | G - Insertion | NA | NA | NA | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 516 | G - Insertion | NA | NA | NA | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -12 | T - C | NA | NA | NA | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 195 - 263 | 68bp - Deletion | NA | NA | NA | Azerbaijan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 407 - 408 | C - Insertion | NA | NA | NA | Azerbaijan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 88 - 112 | 24bp - Deletion | NA | NA | NA | California in United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 287 | T - Insertion | NA | NA | NA | Canada |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 446 | 8bp - Deletion | NA | NA | NA | Canada |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 136 | G - Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 61 | G - Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 158 | 44 bp - Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 232 | C - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 243 | T - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 288 | A - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 341 | ACGCC - Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 342 | GCCAC - Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 376 | GATGAGGTC - Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 392 | G - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 393 | GGT - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 396 | T - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 408 | A - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 408 | CA - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 378 - 387 | 10 bp - Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 - 392 | G - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 - 392 | GG - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 392 | GG - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 57 - 59 | Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 62 - 65 | Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 70 - 74 | Deletion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 52 | GC - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 130 | C - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 139 | CA - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 11 | TAT - TGT | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 397 | T - Insertion | NA | NA | NA | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 403 | C - Insertion | NA | NA | NA | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 388 | AGGTCGATG - Insertion | NA | Arg Ser Met - Insertion | NA | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | Diverse geographical locations |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 192 | A - Insertion | NA | NA | NA | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 215 | 29bp - Insertion | NA | NA | NA | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 306 | C - Insertion | NA | NA | NA | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 341 | 1355bp - Insertion | NA | NA | NA | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 | GG - Insertion | NA | NA | NA | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 419 | 68bp - Deletion | NA | NA | NA | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 436 | G - Deletion | NA | NA | NA | France |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 395 - 411 | 16bp - Deletion | NA | NA | NA | India |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 70 | G - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 99 | C - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 146 | A - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 224 | T - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 231 | G - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 287 | A - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 290 | G - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 312 | G - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 338 | C - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 358 | AGGTCGATG - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 390 | GG - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 | AGGTCGATG - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 | G - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 394 | ATGTGGTCG - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 417 | G - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 469 | CT - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 487 | GT - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 529 | CG - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 542 | AGTT - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 - 392 | GG - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 406 - 509 | 104 bp - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 528 - 529 | GC - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 388 | GAGGTCGAT - Insertion | NA | Glu Val Asp - Insertion | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -7 | T - C | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 106 | 5.3kb - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 392 | G - Insertion | NA | NA | NA | Pakistan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 250 | C - Insertion | NA | NA | NA | Portugal |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 282 | T - Insertion | NA | NA | NA | Portugal |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 381 | 9bp - Deletion | NA | NA | NA | Portugal |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 439 | CG - Insertion | NA | NA | NA | Portugal |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 379 - 389 | 11bp - Deletion | NA | NA | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -12 | T - G | NA | NA | NA | Russia |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 512 | C - Deletion | NA | NA | NA | Rwanda |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 315 | G - Insertion | NA | NA | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 360 | T - Insertion | NA | NA | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 515 | T - Deletion | NA | NA | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 582 | T - Deletion | NA | NA | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 35 | G - Insertion | NA | NA | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 40 | T - Deletion | NA | NA | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -12 | T - C | NA | NA | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -10 | T - C | NA | NA | NA | South Africa |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 12 | T - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 20 | C - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 31 | C - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 56 | A - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 67 | C - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 67 | C - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 77 | CGCCG - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 132 | A - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 182 | A - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 210 | GAT - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 226 | A - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 287 | T - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 301 | G - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 307 | TACAG - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 341 | C - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 368 | 18bp - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 381 | GG - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 382 | AG - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 391 | GG - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 392 | G - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 393 | C - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 406 | G - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 408 | A - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 414 | G - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 418 | G - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 419 | G - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 428 | GG - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 446 | T - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 452 | T - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 465 | T - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 480 | TGAC - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 489 | T - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 501 | T - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 517 | G - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 532 | C - Insertion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -80 | 80 bp - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 151 - 230 | 80bp - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 386 - 389 | ATGT - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 386 -394 | 9 bp - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 454 - 463 | 10 bp - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -71 | G - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -71 | G - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -71 | G - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -71 | G - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -70 | GA - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -70 | GA - Deletion | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | TAT - TG | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | TAT - TG | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | TAT - TG | NA | NA | NA | South Korea |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 168 | C - Insertion | NA | NA | NA | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 207-209 | ACC - Deletion | NA | NA | NA | Taiwan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 411 | G - Insertion | NA | NA | NA | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 520 | GG - Insertion | NA | NA | NA | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - C | NA | NA | NA | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | Thailand |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 102 | 167 bp - Deletion | NA | NA | NA | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 102 | 167 bp - Deletion | NA | NA | NA | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 102 | 167 bp - Deletion | NA | NA | NA | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 239 | A - Deletion | NA | NA | NA | Turkey |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 288 | G - Deletion | NA | NA | NA | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 420 | G - Insertion | NA | NA | NA | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 420 | GG - Insertion | NA | NA | NA | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | NA | NA | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 55 | C - Deletion | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 419 | G - Deletion | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 187-188 | ACTATTCCTC - Insertion | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 231 - 232 | G - Insertion | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 389 -390 | GG - Insertion | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 482 - 483 | G - Insertion | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 491 - 492 | C - Insertion | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -13 | G - T | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -12 | T - G | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -25 | CGAACGTATGGT - Deletion | NA | NA | NA | Vietnam |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -15 | A - C | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 296 -309 | Deletion | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -15 | A - C | NA | NA | NA | Bangladesh |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 193 | TCCTCGTC - Insertion | NA | NA | NA | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 445 | CG - Insertion | NA | NA | NA | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 172 - 173 | TT - Deletion | NA | NA | NA | Brazil |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 306 | T - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 408 | A - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 478 | CCTG - Insertion | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - G | NA | NA | NA | China |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 59 | C - Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 94 | AG - Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 97 | GA - Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 129 | CG - Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 261 | AC - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 261 | AC - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 366 | GTGCGGCA - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 374 | TCGATGAGGTCGATGT - Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 392 | GG - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 522 | G - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | NA | 1565bp - Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | NA | 4475bp - Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | NA | 6258bp - Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -7 | T - C | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 22 | A - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 113 | 9 bp - Deletion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 173 | G - Insertion | NA | NA | NA | NA |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 290 | G - Deletion | NA | NA | NA | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 506 - 513 | Deletion | NA | NA | NA | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -12 | T - G | NA | NA | NA | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - C | NA | NA | NA | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -11 | A - C | NA | NA | NA | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -7 | T - C | NA | NA | NA | Thailand and Tanzania and United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -12 | T - Deletion | NA | NA | NA | Netherlands |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | NA | NA | NA | NA | NA | United Kingdom |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | NA | NA | NA | NA | NA | United Kingdom |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 290 | G - Deletion | NA | NA | NA | United States |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 410 | CAT - CCT | 137 | His - Pro | -8.164 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 153 | CAC - CAA | 51 | His - Gln | -7.728 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 26 | GTG - GGG | 9 | Val - Gly | -6.553 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 232 | GGC - AGC | 78 | Gly - Ser | -5.892 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 100 | TAC - GAC | 34 | Tyr - Asp | -5.411 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 100 | TAC - GAC | 34 | Tyr - Asp | -5.411 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 100 | TAC - GAC | 34 | Tyr - Asp | -5.411 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 8 | GCG - GAG | 3 | Ala - Glu | -4.578 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 8 | GCG - GAG | 3 | Ala - Glu | -4.578 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 8 | GCG - GAG | 3 | Ala - Glu | -4.578 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 175 | TCC - CCC | 59 | Ser - Pro | -4.286 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 419 | CGC - CAC | 140 | Arg - His | -4.164 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 340 | ACG - GCG | 114 | Thr - Ala | -3.541 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 340 | ACG - GCG | 114 | Thr - Ala | -3.541 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 400 | GCC - TCC | 134 | Ala - Ser | -2.799 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 493 | GCC - ACC | 165 | Ala - Thr | -0.929 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 493 | GCC - ACC | 165 | Ala - Thr | -0.929 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 59 | C - Deletion | 20 | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 102 | TAC - TAA | 34 | Tyr - Stop | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 261 | AC - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 261 | AC - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 129 - 130 | CG - Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 374 - 389 | Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -7 | T - C | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | -7 | T - C | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 216 | TGC - TGG | 72 | Cys - Trp | -10.817 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 161 | CCG - CTG | 54 | Pro - Leu | -9.651 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 406 | GAT - TAT | 136 | Asp - Tyr | -8.385 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 153 | CAC - CAG | 51 | His - Gln | -7.728 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 35 | GAC - GCC | 12 | Asp - Ala | -7.68 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 29 | CAG - CCG | 10 | Gln - Pro | -5.758 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 394 | GGT - AGT | 132 | Gly - Ser | -5.572 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 8 | GCG - GAG | 3 | Ala - Glu | -4.578 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 398 | ATT - ACT | 133 | Ile - Thr | -4.447 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 157 | GAC - AAC | 53 | Asp - Asn | -4.099 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 80 | CTG - CCG | 27 | Leu - Pro | -3.201 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 523 | ATG - GTG | 175 | Met - Val | -1.826 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 442 | CGC - AGC | 148 | Arg - Ser | -1.796 | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 349 | CACTG - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 420 | G - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 493 | C - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 386 -388 | ATG - Deletion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | NA | CGCATTGCCG - Insertion | NA | NA | NA | Japan |
| Mycobacterium tuberculosis | pncA | Rv2043c | Pyrazinamide | 485 | GGT - GAT | 162 | Gly - Asp | -6.179 | NA |